Sativex for MS-related spasticity

It has been a long haul, but finally another option for people with MS-related spasticity.

Click here for press release

The signficance of this license cannot be under estimated; particularly as the registration study will probably set a precedent for how spasticity studies are done in the future. The Ashworth Scale has had its day and is seriously flawed as an outcome measure. This result can also be viewed as a victory for patient-related outcome measures or PROMS.

Leave a ReplyCancel reply

Discover more from Prof G's MS Blog Archive

Subscribe now to keep reading and get access to the full archive.

Continue reading

Exit mobile version
%%footer%%